Insider Trades: Penny Stocks Under $1 Insider Trades: Penny Stocks Under $1

Photo of author

By Ronald Tech

The Dow Jones index closed slightly higher on Thursday. Whenever insiders buy or sell shares, it reflects their confidence or concerns about the company’s prospects. Investors and traders who dabble in penny stocks should consider this a factor in their overall investment or trading decision.

Here is an overview of recent noteworthy insider transactions for penny stocks. For more, explore Benzinga’s insider transactions platform.

Entera Bio

  • The Trade: Entera Bio Ltd. ENTX Director Haya Taitel acquired a total of 7,615 shares at an average price of $0.77. The purchase amounted to approximately $5,86.
  • What’s Happening: Entera Bio announced that it received an extension of 180 calendar days from the Nasdaq stock market to regain compliance.
  • What Entera Bio Does: Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins.

OPKO Health

  • The Trade: OPKO Health, Inc. OPK 10% owner Frost Gamma Investments Trust acquired a total of 511,531 shares at at an average price of $0.94. The purchase amounted to around $480,379.
  • What’s Happening: OPKO Health recently priced a private offering of $200 million convertible senior notes due 2029.
  • What OPKO Health Does: OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs.

Explore This: Citigroup, Bank of America And 3 Stocks To Watch Heading Into Friday

Fresh Tracks Therapeutics

  • The Trade: Fresh Tracks Therapeutics, Inc. FRTX 10% owner Exploration Capital LLC acquired a total of 51,502 shares at an average price of $0.98. The insider spent around $50,472 to make this purchase.
  • What’s Happening: Fresh Tracks Therapeutics plans to hold a new special meeting of stockholders on Feb. 15, 2024, to seek stockholder approval of liquidation.
  • What Fresh Tracks Therapeutics Does: Fresh Tracks Therapeutics Inc is a clinical-stage pharmaceutical company striving to transform patient lives through the development of innovative and differentiated prescription therapeutics.
See also  Cannabis Industry Analysis Examining Cannabis EBITDA Projections and Market Trends

Vista Gold

  • The Trade: Vista Gold Corp. VGZ Director Tracy Austin Stevenson acquired a total of 20,000 shares at an average price of $0.37. The insider spent around $7,324 to purchase these shares.
  • What’s Happening: Vista Gold recently announced it will receive $20 million from Wheaton Precious Metals as part of a royalty agreement related to the company’s Mt Todd gold project.
  • What Vista Gold Does: Vista Gold Corp is a gold mining company. It is engaged in the evaluation, acquisition, exploration, and advancement of gold exploration and potential development projects.

Remember to check out our premarket coverage here